Stada CEO Anticipates Robust Investor Interest for Upcoming European IPO

Stada, a prominent European pharmaceutical company, is gearing up for what is anticipated to be one of the region's largest initial public offerings (IPOs) in recent history. CEO Peter Goldschmidt shared insights about the IPO process during a recent interview, projecting strong demand from investors keen on entering the pharmaceutical sector. The company's potential listing has captured attention amidst a slowly recovering stock market and an increasing appetite for shares in the healthcare industry.

Continue reading